Impact Biomedical Inc. SEC filings IBO
Impact Biomedical Inc. has 146 filings in SEC EDGAR's recent list, going back to Feb 12, 2021. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFM14A | Filing | Oct 27, 2026 | — |
| DEF 14C | Information statement | Dec 30, 2025 | Dec 30, 2025 |
| PRE 14C | Filing | Dec 11, 2025 | Dec 11, 2025 |
| DEF 14A | Proxy statement | Sep 22, 2025 | Sep 22, 2025 |
| DEF 14C | Information statement | Sep 9, 2025 | Sep 9, 2025 |
| PRE 14C | Filing | Aug 25, 2025 | Aug 25, 2025 |
| DEF 14C | Information statement | Aug 5, 2025 | Aug 5, 2025 |
| PRE 14C | Filing | Jul 16, 2025 | Jul 16, 2025 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Henrietta, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1834105
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.